Loeb & Loeb represented GenNx360 and Nutra-Med, while Polsinelli represented Legacy Pharma Solutions in the transaction. Nutra-Med, a portfolio company of GenNx360 Capital Partners and a...
Nutra-Med’s Acquisition of Legacy Pharma Solutions
Genenta Science S.p.A.’s Initial Public Offering On Nasdaq
IN BRIEF: Emmet, Marvin & Martin, LLP, Giovannelli e Associati Studio Legale, Goodwin Procter, Loeb & Loeb LLP, Spada Partners, advised on the matter. Emmet, Marvin...
Genenta Science S.p.A.’s Initial Public Offering On Nasdaq
Goodwin Procter advised the underwriters on the deal. Genenta Science S.p.A.’s (Nasdaq: GNTA) announced its upsized initial public offering, making history as the first Italian biotech to...